BAILII is celebrating 24 years of free online access to the law! Would you consider making a contribution?
No donation is too small. If every visitor before 31 December gives just £1, it will have a significant impact on BAILII's ability to continue providing free access to the law.
Thank you very much for your support!
 |
[Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback] | |
Information Commissioner's Office |
||
|
You are here: BAILII >> Databases >> Information Commissioner's Office >> Medicines and Healthcare Products Regulatory Agency (Decision Notice) [2014] UKICO FS50518495 (19 February 2014) URL: http://www.bailii.org/uk/cases/UKICO/2014/FS50518495.html Cite as: [2014] UKICO FS50518495 |
||
[New search] [Printable PDF version] [Help]
Summary: The complainant has requested legal advice obtained by the Medicines and Healthcare Products Regulatory Agency (MHRA) related to the licensing of nicotine containing products (NCP) and nicotine replacement therapies (NRT) as medicines. The Commissioner-™s decision is that MHRA has correctly applied section 42(1) of the FOIA to the withheld information. The Commissioner does not require the public authority to take any steps as a result of this decision notice.
Section of Act/EIR & Finding: FOI 42 - Complaint Not upheld
